ArticlePulmonary therapy2026

Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES Study.

Bernardino Alcázar-Navarrete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.